Get started
Author

Md. Rizwanullah

Observed names: M.D. Rizwanullah, Md Rizwanullah
ORCID: 0000-0003-1394-7298
Observed ORCID: 0000-0003-1394-7298
OpenAlex ID: A5004657403
PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges
2019 · Mohammad A. Khan, Vineet K. Jain, et al. · Drug Discovery Today · 246
Nanotechnology-based inhalation treatments for lung cancer: state of the art
2015 · Sohail Akhter, Javed Ahmad, et al. · Nanotechnology Science and Applications · 175
PDF
Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment
2020 · Zoya Saifi, Md. Rizwanullah, et al. · Journal of Drug Delivery Science and Technology · 136
Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics
2017 · Md. Habban Akhter, Md. Rizwanullah, et al. · Artificial Cells Nanomedicine and Biotechnology · 128
PDF
Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro , ex vivo and in vivo assessments
2017 · Kriti Soni, Md. Rizwanullah, et al. · Artificial Cells Nanomedicine and Biotechnology · 115
PDF
Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy
2021 · Mohammad Zaki Ahmad, Md. Rizwanullah, et al. · International Journal of Polymeric Materials · 114
Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives
2021 · Syed Sarim Imam, Sultan Alshehri, et al. · Polymers · 112
PDF
Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments
2020 · Mohammed Shadab Shahab, Md. Rizwanullah, et al. · International Journal of Biological Macromolecules · 108
Phytochemical based nanomedicines against cancer: current status and future prospects
2017 · Md. Rizwanullah, Saima Amin, et al. · Journal of drug targeting · 107
Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges
2020 · Sultan Alshehri, Syed Sarim Imam, et al. · Pharmaceutics · 104
PDF
Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers
2016 · Md. Rizwanullah, Saima Amin, et al. · Journal of drug targeting · 95
Nanostructured Lipid Carriers: A Novel Platform for Chemotherapeutics
2016 · Md. Rizwanullah, Javed Ahmad, et al. · Current Drug Delivery · 95
Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides
2017 · Javed Ahmad, Madhur Singhal, et al. · Current Pharmaceutical Design · 91
Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective
2017 · Javed Ahmad, Sohail Akhter, et al. · Current Alzheimer Research · 81
Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma
2019 · Harshita, Md Abul Barkat, et al. · AAPS PharmSciTech · 79
Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors
2020 · Md. Rizwanullah, Meraj Alam, et al. · Current Pharmaceutical Design · 73
Cilnidipine loaded transfersomes for transdermal application: Formulation optimization, in-vitro and in-vivo study
2019 · Karishma Khatoon, Md Rizwanullah, et al. · Journal of Drug Delivery Science and Technology · 73
Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges
2021 · Md. Rizwanullah, Mohammad Zaki Ahmad, et al. · Pharmaceutics · 68
Chitosan Coated Luteolin Nanostructured Lipid Carriers: Optimization, In Vitro-Ex Vivo Assessments and Cytotoxicity Study in Breast Cancer Cells
2021 · Sadaf Jamal Gilani, May Bin-Jumah, et al. · Coatings · 68
PDF
Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application
2021 · Md. Rizwanullah, Mohammad Zaki Ahmad, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 60
Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application
2020 · Javed Ahmad, Md. Rizwanullah, et al. · Current Drug Metabolism · 59
Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies
2021 · Md Rizwanullah, Ahmad Perwez, et al. · Nanotechnology · 57
PDF
Nanomedicines in Diagnosis and Treatment of Cancer: An Update
2020 · Nafis Haider, Sana Fatima, et al. · Current Pharmaceutical Design · 56
Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments
2021 · Iqra Rahat, Syed Sarim Imam, et al. · Drug Delivery · 51
PDF
Effect of Chitosan Coating on PLGA Nanoparticles for Oral Delivery of Thymoquinone: In Vitro, Ex Vivo, and Cancer Cell Line Assessments
2020 · Sultan Alshehri, Syed Sarim Imam, et al. · Coatings · 50
PDF
Works count: 70
Citation count: 3,207
H-index: 35
I10-index: 48
Year
Topic
Type